Surgical Robots Market (2026 - 2033) Size, Share & Trends Analysis Report By Component (Instruments & Accessories, Robotic Systems, Services), By Application (Orthopedics, Urology, Gynecology, Neurology), By End-use (Inpatient, Outpatient), By Region, And Segment Forecasts

Surgical Robotics Market Summary

The global surgical robots market size was valued at USD 6.6 billion in 2025 and is projected to reach USD 18.5 billion by 2033, growing at a CAGR of 13.5% from 2026 to 2033. The global shortage of physicians and surgeons, with growing adoption of automated surgical instruments and accessories, significantly contributes to market expansion.

Technological advancements, increased investments from regional and international stakeholders, and the rising prevalence of chronic diseases, particularly in knee and hip replacement surgeries, are key drivers of this market growth. In March 2025, according to the American College of Rheumatology, over 790,000 knee and 544,000 hip replacements are performed annually in the U.S., reflecting a steady increase as the population ages.

Surgical Robots Market Driver Analysis

Rising Prevalence of Joint-Related Health Issues and Growing Geriatric Population

The rising prevalence of joint-related health issues and an aging population is driving demand for orthopedic procedures. Growing patient expectations for quicker recovery and improved mobility further strengthens the need for advanced and effective treatment solutions. In November 2024, as per the American Academy of Orthopedic Surgeons (AAOS) study, over 3.7 million total hip and knee replacement surgeries took place at 1,447 facilities across all 50 states by 2023.

Advantages associated with these medical procedures include less pain & blood loss, shorter recovery period, lower risk of infections at the site, and smaller or less noticeable scars, aiding market growth. For instance, a study published by The Journal of Arthroplasty in July 2025 found that robotic-assisted primary total knee arthroplasty was associated with few soft tissue releases and great reductions in early postoperative pain compared to conventional surgery.

Increasing Prevalence of Bone Degenerative Diseases

The increasing prevalence of bone degenerative diseases, such as arthritis and osteoporosis, is driving a surge in hip and knee replacement surgeries, significantly impacting market growth. Osteoporosis impacts around 10 million individuals in the U.S., and approximately 75 million people across the U.S., Europe, and Japan collectively. Projections suggest that by 2040, 1 in 4 U.S. adults (78.4 million) will have doctor-diagnosed arthritis, and 1 in 9 adults (34.6 million) will experience arthritis-attributable activity limitations. As the demand for joint replacement procedures rises, advancements in robotic-assisted surgery are transforming the orthopedic landscape by improving precision, reducing recovery times, and enhancing patient outcomes.

Advancements in Surgical Visualization and Navigation Technologies

Enhancements in visualization and navigation, particularly through surgical navigation systems, are essential for the technological advancement of robotic surgical procedures. High-definition 3D cameras and augmented reality overlays provide surgeons with an immersive perspective of the operative area, improving their spatial awareness and decision-making skills. For instance, in February 2024, CMR Surgical launched its latest innovation, the vLimeLite. This integrated fluorescence imaging system is designed to enhance procedures by providing surgeons with improved visualization capabilities using Indocyanine Green (ICG). ICG is a fluorescent dye that is commonly used in medical imaging to visualize blood flow and tissue perfusion.

In January 2026,  the American College of Surgeons reported that over 12 million surgeries had been performed using da Vinci systems globally. This surge in demand reflects the effectiveness of robotic systems and a shift in practices towards minimally invasive techniques that improve patient outcomes and reduce recovery times.

Surgical Robots Market Restraint Analysis

High Cost Associated with Devices

The surgical robots market faces significant cost-related challenges that are likely to hinder broader adoption, especially in healthcare settings with tight budgets. These robots typically involve substantial upfront costs, along with expenses for installation, integration, and operating room modifications. Hospitals must also account for recurring costs such as maintenance contracts, software upgrades, and disposable instruments per procedure. In price-sensitive markets and mid-sized healthcare facilities, these costs limit adoption despite clinical benefits.

Source: Secondary Research, Grand View Research

Surgical Robots Market Opportunity Analysis  

Expansion of Cross-Border Telesurgery and Remote Intervention

Telesurgery, enabled by 5G and low-latency satellite communication, addresses the global shortage of specialized surgeons and disparities in healthcare access. Specialists can now perform life-saving procedures for patients in rural or underserved areas without travel. Manufacturers are developing modular systems that operate across long distances, decentralizing specialized care and establishing a new service-based economy for remote medical consultation and intervention. For instance, in April 2025, SS Innovations performed robotic cardiac telesurgery using the SSI Mantra 3 system, connecting Gurugram to Aster CMI Hospital in Bengaluru. 

Moreover, in November 2025, SS Innovations International introduced MantrAsana, the world’s first portable Tele Surgeon Console, which enables remote procedures without a full operating room. Recent advancements demonstrate that latency and connectivity challenges are being effectively addressed, facilitating the development of commercial Telesurgery Centers that function as hubs for regional and international surgical expertise.

Systems constitute the most complex part of products and include various hardware components & software solutions. This system enables the surgeon(s) to control the robotic arms and perform surgeries remotely. Some of the components of the system are the surgeon console, patient cart, vision cart, and robotic arms.

Product Pipeline Analysis, By Stage

Comparative Market Analysis: Single-Port vs Multiport Robotic Surgery Platforms

New Surgical Robotics Platforms Emerging Globally

Market Dynamics

The surgical robots market is characterized by a high degree of innovation. The latest technological advancements in medical robotic systems include improved articulation, tremor filtration, and visualization, enabling surgeons to conduct intricate procedures with unparalleled accuracy and minimal tissue damage. For instance, in July 2025, Wockhardt Hospitals Mira Road launched the MISSO Robotic System for advanced robotic-assisted knee replacement surgeries in India. The system was introduced to enhance surgical precision, minimize tissue damage, support faster recovery, and improve post-operative outcomes for orthopedic patients undergoing minimally invasive knee replacement procedures.

The surgical robots market is characterized by moderate merger and acquisition activity, owing to several factors, including the desire to expand the business to cater to the growing demand for robotics surgery to maintain a competitive edge. For instance, in August 2024, Asensus Surgical announced the completion of its acquisition of Karl Storz, a manufacturer of endoscopic equipment. This strategic move is aimed at enhancing Asensus Surgical’s capabilities in the field of minimally invasive surgery by integrating Karl Storz’s extensive product portfolio and expertise in visualization technologies.

Asensus Surgical President and CEO said,“By joining forces with a leading company in endoscopy that became a system provider for integrated MedTech, we are well-positioned to accelerate the development and delivery of our innovative robotic and digital surgical solutions. This union will benefit patients and surgeons worldwide by advancing precise, safer, and more predictable surgical outcomes."

Surgical robots are presently approved in the U.S. by the FDA and by the EU & CEA in Europe. Certification by these authorities is required for the commercialization and marketing of these devices in 27 EU nations. Surgical robots are classified as Class-II devices as per the U.S. FDA risk-based classification and Class IIa (low risk) or Class IIb (high risk) in Europe. For any medical device, the process of securing the U.S. FDA 510(k) premarket approval & Europe CE Mark is a major barrier to commercializing the product and requires a considerable investment of time and resources.

Several market players are expanding their business by launching new products and getting approvals from regulatory authorities to strengthen their market position and expand their product portfolio. For instance, in November 2024, Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration (FDA) approved the OTTAVA robotic system under an investigational device exemption (IDE). This approval allows the company to begin clinical trials with this advanced clinical technology.

Component Insights

The instruments & accessories segment accounted for the largest share of around 60.0% in 2025, owing to the recurring demand for robotic consumables, staplers, vessel sealers, scissors, and imaging accessories used during every robotic-assisted procedure. An increasing number of minimally invasive surgeries across urology, gynecology, thoracic, and general surgery further supports this segment growth. Companies are focused on launching advanced robotic instruments and accessories with improved precision and single-port surgical capabilities. For instance, in July 2025, Intuitive Surgical received U.S. FDA clearance for its Vessel Sealer Curved instrument used in the da Vinci robotic systems. This new instrument aims to enhance its surgical precision and support the expansion of robotic-assisted surgeries, further contributing to the growth of this segment.

The robotic systems segment is expected to witness significant growth over the forecast period due to rising demand for minimally invasive surgeries, increasing chronic disease burden, expansion of ASCs, and growing investments in advanced robotic operating rooms. Companies are introducing advanced robotic platforms with enhanced visualization, AI integration, force feedback, and greater surgical flexibility, while regulatory approvals across specialties such as urology, gynecology, and general surgery further support market growth. For instance, in March 2026, CMR Surgical reported that over 45,000 procedures had been completed globally using its Versius robotic system ahead of its U.S. launch, reflecting strong adoption and market expansion. Increasing competition among manufacturers is also driving innovation and broader accessibility of robotic-assisted surgical systems.

Application Insights

The orthopedics segment held a significant market share of 19.8% in 2025, driven by the growing number of joint replacement surgeries, the developing need for precise alignment in knee and hip operations, and the increasing use of robotic systems that enhance surgical accuracy and patient results. Moreover, advancements in medical instruments and accessories used in surgical robots are also contributing to the growth of the segment. In July 2025, Zimmer Biomet announced its acquisition of Monogram Technologies, totaling around USD 177 million, aimed at enhancing its robotics portfolio. This strategic move will integrate Monogram's semi- and fully autonomous robotic technologies into Zimmer Biomet’s ROSA platform. The acquisition is expected to strengthen Zimmer Biomet's position in the orthopedic robotics market and contribute to revenue growth starting in 2027.

The neurology segment is anticipated to grow at the fastest CAGR over the forecast period due to the rising prevalence of neurological disorders, increasing demand for minimally invasive brain and spine surgeries, and growing adoption of robotic-assisted procedures. Advancements in AI-integrated navigation systems, real-time imaging, and robotic-assisted spine surgeries are further supporting segment growth. For instance, in May 2026, MMI (Medical Microinstruments) announced that its Symani Surgical System treated the first Alzheimer’s patient in the FDA-approved REMIND clinical study, highlighting the expanding role of robotic-assisted microsurgery in neurology.

End-use Insights

By end use, the inpatient (hospital) segment dominated the market with a revenue share of 52.9% in 2025, as healthcare facilities are increasingly adopting robotic technology, advanced robotic instruments, and accessories to enhance medical procedures. These advanced robots offer precision, minimally invasive techniques, and improved patient outcomes. In January 2025, Prashanth Hospitals inaugurated the Institute of Robotic Surgery, introducing a medical robotic system designed for minimally invasive surgeries. With its features designed to enhance precision and patient safety, along with its applicability across various specialties, this innovation is expected to transform how surgeries are performed.

The outpatient segment is anticipated to grow at the fastest CAGR over the forecast period. These facilities offer patients minimally invasive and highly precise surgeries, resulting in quicker recovery times and reduced healthcare costs. The growing trend towards outpatient robotic surgeries strengthens the industry's commitment to providing accessible, efficient, and patient-centric medical solutions outside traditional hospital settings. In September 2025, Memorial Care launched the advanced da Vinci 5 robotic surgical system across its hospitals, including Orange Coast Medical Center, Saddleback Medical Center, and Long Beach Medical Center in California, U.S. The platform expanded minimally invasive robotic-assisted procedures across multiple specialties, enhancing surgical precision, workflow efficiency, and patient outcomes through next-generation robotic technology.

Regional Insights

North America dominated the surgical robots market with a revenue share of 51.3% in 2025. The advancements in surgeries and healthcare facilities for various disorders are increasing the need for these systems for surgeries and treatment in North America. Diligent R&D pertaining to ergonomically designed workstations to improve learning curves and growing clinical adoption of new minimally invasive surgery techniques is expected to boost market demand. In March 2024, Intuitive Surgical obtained FDA 510(k) clearance for its new multiport robotic system, da Vinci 5. The system advances the capabilities of the da Vinci Xi, previously used in over 7 million operations worldwide, setting a new standard for minimally invasive procedures.

U.S. Surgical Robots Market Trends

The U.S. dominated the surgical robots market in North America region in 2025. The growing adoption of minimally invasive procedures in the country due to the need for a shorter recovery period is anticipated to drive market growth. The presence of a well-developed healthcare infrastructure in the country, ongoing advancements in robots, and the presence of key market players contribute to market expansion. In April 2025, Medtronic submitted its Hugo robotic-assisted surgery system to the U.S. FDA after meeting primary safety and effectiveness endpoints in an IDE study, with the system showing a 98.5% clinical success rate.

Europe Surgical Robots Market Trends

The surgical robots market in Europe is expected to grow significantly over the forecast period. Factors such as the presence of a well-developed healthcare infrastructure and favorable reimbursement policies that reduce the out-of-pocket expenditure of patients boost demand. Ongoing research on robots in the region is expected to also contribute towards market growth over the forecast period. In July 2025, Intuitive Surgical’s da Vinci 5 Surgical System received CE mark approval for adult and pediatric use in Europe, covering minimally invasive procedures across urologic, gynecologic, and general laparoscopic surgeries.

The surgical robots industry in Germany is expected to grow significantly during the forecast period. The presence of high-quality healthcare infrastructure and favorable reimbursement policies is a key factor expected to drive this market. Various factors driving the market in Germany include increasing government initiatives for launching local robots and continuous improvements in robots & medical technology in the country

Asia Pacific Surgical Robots Market Trends

The Asia Pacific surgical robots industry is expected to register the fastest growth rate over the forecast period. Increasing government initiatives undertaken to encourage healthcare providers and other healthcare organizations to adopt technologically advanced medical devices & systems are a key factor expected to drive this market. In terms of adoption of technology in the Asia Pacific, Japan, Singapore, Australia, and South Korea have been adopting technology on a large scale in the healthcare sector, whereas Thailand, China, India, and Malaysia are the emerging markets. In May 2025, MicroPort MedBot received market approval from China’s National Medical Products Administration for its Toumai Tele-Robotic Surgical System.

China surgical robots market is anticipated to register considerable growth during the forecast period. Increasing partnerships and the launch of products in the Chinese market are expected to drive market growth. Growing modernization of domestic production facilities is leading to the increase in the manufacturing of medical robots in China. China’s use of robotic systems combined with satellite communication represents a significant step forward in remote surgery capabilities, potentially transforming how medical care is delivered across great distances. For instance, in January 2025, Chinese surgeons have successfully conducted remote surgeries using advanced robotic systems and satellite technology. This innovative approach allows surgeons to operate on patients located thousands of kilometers away, demonstrating a significant advancement in medical technology.

Latin America Surgical Robots Market Trends

The Latin America surgical robots industry is expected to witness significant growth over the forecast period. The growing prevalence of chronic diseases, easy availability of newer technologies & robots, and increasing prevalence of osteoporosis are among key factors driving market growth in this region. For instance, according to the International Osteoporosis Foundation, in Latin America, the economic burden of hip fractures would cost USD 13 billion by 2050.

Brazil surgical robots industry is anticipated to register significant growth during the forecast period. As per estimates of the World Bank, Brazil spends nearly 9.5% of its GDP in the healthcare sector and is one of the fastest-growing industries in Latin America, owing to its leading healthcare expenditure. In January 2025, MicroPort MedBot’s SkyWalker orthopedic operative robot successfully performed its inaugural total knee arthroplasty in South America at Vera Cruz Hospital in Brazil. The operation showcased accurate bone registration and osteotomy that aligned with the preoperative plans, minimizing trauma and complications.

Middle East and Africa Surgical Robots Market Trends

The Middle East and Africa surgical robots market is anticipated to witness significant growth over the forecast period. High cancer incidence and lack of skilled professionals in this region are boosting the need for robotic-assisted surgeries. In January 2025, King Faisal Specialist Hospital and Research Centre (KFSH&RC) successfully performed a groundbreaking medical procedure. This event marks an important advancement in healthcare services provided by the institution, which is known for its commitment to excellence in patient care and medical research.

South Africa surgical robots industry is anticipated to register substantial growth during the forecast period. There is a significant shift in the medical technology (medtech) landscape in Africa, particularly focusing on the introduction of the Da Vinci Surgical Robot and its pay-per-use equipment model. The installation of a Da Vinci robot at Busamed Gateway Private Hospital in KwaZulu-Natal in August 2024 represents a significant advancement in the accessibility of advanced medical technology in Africa. It allows healthcare facilities to utilize state-of-the-art robotic surgery without incurring the substantial capital costs typically associated with such technologies.

Competitive Benchmarking

Recent Developments

• In May 2026, Johnson & Johnson announced positive clinical study results for its OTTAVA soft-tissue robotic surgical system, highlighting the growing adoption of robotic-assisted surgeries and advancements in minimally invasive surgical technology.

• In March 2026, CMR Surgical partnered with NVIDIA to develop and train next-generation AI-powered robotic surgery systems by contributing surgical data to Open-H, the world’s largest open robotics dataset. This strategy aims to support faster innovation and growth in the global surgical robotics market.

• In July 2025, Care Hospitals in Hyderabad introduced the AI-driven Stryker Mako Robotic System to aid in robotic-assisted joint replacement surgeries. The system combines 3D CT-based surgical planning with real-time guidance, aiming to improve surgical accuracy while minimizing tissue damage.

• In June 2025, SS Innovations performed the first robotic cardiac surgery in the Americas using its SSi Mantra 3 system at Interhospital, Ecuador, with successful patient outcomes. The company is expanding globally, aiming for FDA clearance in 2026, and has 80 systems installed across 75 hospitals in India and other countries.

• In April 2025, Johnson & Johnson MedTech announced the successful completion of the first clinical cases using the OTTAVA Robotic Surgical System for gastric bypass surgery at Memorial Hermann-Texas Medical Center.

• In April 2025, Intuitive announced the FDA clearance of its SureForm 45 stapler for use in single-port robotic surgery, specifically for urology procedures. This stapler features SmartFire technology, enhancing surgical precision by monitoring tissue compression in real time

• In June 2024, Indian medical device company Meril launched its MISSO surgical robot for knee replacement surgeries, claiming a 98% success rate. This indigenously developed system is designed to be cost-effective, reducing investment by 66% compared to imported systems. It makes robotic surgery more accessible, especially in smaller hospitals. The technology has received approval from CDSCO and is awaiting CE and USFDA approvals.

• In June 2024, Smith+Nephew introduced a new service called CORIOGRAPH, which is designed to enhance the capabilities of their CORI Surgical System. This service focuses on personalized pre-operative planning and modeling for both patients and surgeons. The aim is to improve surgical outcomes by providing tailored insights that can help with decision-making prior to surgery.

Surgical Robots Market Report Scope

Global Surgical Robotics Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global surgical robots market report based on component, application, end-use, and region:

• Component Outlook 2021 - 2033 (Revenue, USD Million, 2021 - 2033)

  • Instruments & Accessories

  • Robotic Systems

  • Services

• Application Outlook 2021 - 2033 By Revenue (USD Million) Procedure Volume (Surgeries Performed, 000), By Unit Volume 2021 - 2033 (Systems Installed, 000)

  • Orthopedics

    • Hip

    • Knee

    • Spine 

    • Others

  • Urology

  • Gynecology

  • Neurology 

  • Others

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Inpatient

  • Outpatient

• Regional Outlook 2021 - 2033 By Revenue (USD Million) Procedure Volume (Surgeries Performed, 000), By Unit Volume 2021 - 2033 (Systems Installed, 000)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait